Company Active LTD

Company profile

Reacta Biotech Limited

UK company 08553682, incorporated on 3 June 2013.

Reacta Healthcare Integrating Food Science with Medicine

Reacta Biotech Limited is a UK company with status Active founded in 2013 based in North West England.

Company number
08553682
Incorporated
3 Jun 2013
Companies House status
Active

Company identity

Founded / incorporated
3 June 2013

Company number 08553682

Verify at Companies House
Legal name
REACTA BIOTECH LIMITED
Company type
Private Limited Company
Region
North West England
Registered address
UNIT 2 NEWTECH SQUARE
DEESIDE INDUSTRIAL PARK
DEESIDE
ENGLAND
CH5 2NT
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

11 events
23 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

21 Aug
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzU0MDI5NTc1OWFkaXF6a2N4

Published 21 Aug 2026 14:52

06 Aug
2026

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzUzNzIwMjE1MGFkaXF6a2N4

Published 06 Aug 2026 09:19

05 Aug
2026

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzUzNzIwMTY2M2FkaXF6a2N4

Published 05 Aug 2026 11:21

19 Jun
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUyNzM5MDM5N2FkaXF6a2N4

Published 19 Jun 2026 17:44

09 Jun
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

14 Jun
2018

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzIwNzM4NTU0M2FkaXF6a2N4

Published 28 Jul 2026 12:16

22 Apr
2016

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzE0NjkzNjkzM2FkaXF6a2N4

Published 28 Jul 2026 12:16

03 Jun
2013

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2022
Funded years
2022
Age at first award
8 years

Projects

2022 Collaborative R&D Lead participant

Transforming oral food challenges for gold-standard food allergy diagnosis and management in young children

1 Apr 2022 to 31 Mar 2024

Awarded
£655,155
Total cost £935,936

Food allergy (FA) prevalence and hospitalisations are rising, especially in young children. Sufferers and their families face possible death from anaphylaxis, social exclusion, reduced Quality of Life, and high out-of-pocket costs. New treatments promise to revolutionise FA, stimulating strong demand for partner diagnostics. Today's gold-standard FA diagn...

Product types

Collaborative R&D